Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer
Authors:
- 1 May 2018
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 94, 1-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Adjuvant chemotherapy is not associated with improved survival for all high‐risk factors in stage II colon cancerInternational Journal of Cancer, 2016
- Preoperative serum markers for individual patient prognosis in stage I–III colon cancerTumor Biology, 2015
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and ElaborationPLOS Medicine, 2012
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic FeaturesJournal of Clinical Oncology, 2011
- Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancerJournal of Surgical Oncology, 2008
- Identification of Patients with High-Risk Stage II Colon Cancer for Adjuvant TherapyDiseases of the Colon & Rectum, 2008
- Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal CancerCancer Investigation, 2005
- The National Cancer Data Base: A clinical surveillance and quality improvement toolJournal of Surgical Oncology, 2003
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987